CLINICAL_TRIALS
trial_result
· 2023-04-18
Clinical Trial Update: MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age [Phase 3]
Summary
A Phase 3 noninferiority study evaluating MenABCWY vaccine in healthy adolescents and young adults completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Meningococcal Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2023-04-18